These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3839816)

  • 1. Borderline reactions treated with clofazimine and corticosteroids.
    Thirugnanam T; Rajan MA
    Indian J Lepr; 1985; 57(1):164-71. PubMed ID: 3839816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial with clofazimine in leprosy.
    Ganapati R; Dongre VV
    Lepr India; 1976 Oct; 48(4 Suppl):703-8. PubMed ID: 1026807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the article "Borderline reactions treated with clofazimine and corticosteroids".
    Udaya Kiran K; Suneetha S
    Indian J Lepr; 1986; 58(1):168-71. PubMed ID: 3745993
    [No Abstract]   [Full Text] [Related]  

  • 4. Limitations of clofazimine in the treatment of lepra reactions.
    Mishra B; Girdhar BK
    Indian J Lepr; 1986; 58(1):73-8. PubMed ID: 3746000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofazimine in lepra (ENL) reaction, one year clinical trial.
    Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
    Lepr India; 1983 Apr; 55(2):265-77. PubMed ID: 6355652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of corticosteroid-dependent lepromatous patients in persistent Erythema nodosum leprosum with clofazimine.
    Imkamp FM
    Lepr Rev; 1973 Sep; 44(3):127-30. PubMed ID: 4788877
    [No Abstract]   [Full Text] [Related]  

  • 7. Side effects of clofazimine therapy.
    Ramu G; Iyer GG
    Lepr India; 1976 Oct; 48(4 Suppl):722-31. PubMed ID: 1026810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine.
    Freerksen E; Seydel JK
    Arzneimittelforschung; 1992 Oct; 42(10):1243-5. PubMed ID: 1472145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative evaluation of levamisole in leprosy.
    Sharma L; Thalliath GH; Girgia HS; Sen PC
    Indian J Lepr; 1985; 57(1):11-6. PubMed ID: 3839808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of reactions in leprosy.
    Ramu G
    J Indian Med Assoc; 1973 Nov; 61(9):403-6. PubMed ID: 4799712
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sensory-motor neuropathy: a slow and misleading case of leprosy].
    Gabelle A; Vallat JM; Flageul B; Andre P; Camu W
    Rev Neurol (Paris); 2008 Nov; 164(11):964-8. PubMed ID: 18808760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
    Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
    Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofazimine: new products. Major antileprous drug.
    Prescrire Int; 1999 Apr; 8(40):44-6. PubMed ID: 10848059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment: clofazimine-induced lymphoedema.
    Oommen T; Natu MV; Wilfred D
    Lepr Rev; 1991 Sep; 62(3):341-2. PubMed ID: 1795597
    [No Abstract]   [Full Text] [Related]  

  • 17. Experiences with clofazimine therapy in leprosy.
    Kundu SK; Hazra SK; Choudhury S; Ghosh S
    Lepr India; 1976 Oct; 48(4 Suppl):695-702. PubMed ID: 1026806
    [No Abstract]   [Full Text] [Related]  

  • 18. Lamprene (clofazimine) and its side effects.
    Salafia A; Kharkar RD
    Indian J Lepr; 1987; 59(3):313-4. PubMed ID: 3440850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 20. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.